Skip to content

PATHOSENSE

Active
Private limited companyfounded 2020active for 6 yearsPastoriestraat 10, 2500 Lier, BelgiumKBO/BCE: BE 0755.557.744
Summary

PATHOSENSE has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €157,114 and a net result of €94,137. Equity has been growing by about 89% per year since 2021. Its solvency ranks better than 15% of 1,598 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 01-10-2020 Normal situation
Activity
Veterinary services NACE 75000and 3 others
Establishment units
2.308.456.280 2500 Lier, since 01-10-2020
2.366.356.273 9051 Ghent, since 01-10-2024
Financial year end
31 December
Peppol
Reachable since 27-01-2026

Board and ownership

Board
  • Nauwynck HansDirector
  • Sebastiaan TheunsDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€692,475
▲ 27.8%
Turnover
≈ €1.4m
estimated
Profit
€94,137
▲ 29.4%
Equity
€157,114
▲ 149%
Total assets
€1.2m
▲ 37.8%
Employees on 31-12-2025
8
▲ 14.3%
Score breakdownraises riskEquity €157,114 (13.0% of total assets)lowers riskSector: Veterinary activities (NACE 75)Size: total assets €1.2mFigures for financial year 2025 (filed on 27-03-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies in veterinary activities (NACE 75)
Financial strength · tick: 2024
Strong
Solvency 38+6
equity 13.0% of total assets
Liquidity 63+4
short-term debt 25.9% · cash 18.3%
Profitability 79=
return on assets 7.8%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,967 companies, NACE 75, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.4%▲ +0.1 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026lowest value 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.72 (3.14 in 2024), above the usual 1.5. Short-term debt is 25.9% and cash 18.3% of total assets. However, 87% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 75, micro). It does better than 17% of them on solvency, 48% on liquidity, 32% on profitability and 95% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Veterinary activities (NACE 75)
KBO
lowers risk · Size: total assets €1.2m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €157,114 (13.0% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 27-03-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 1598 sector peers (2025).
NBB · sector comparison
Position among 1598 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
126 days early
2024
29 days early
2023
58 days late
2022
31 days late
2021
13 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 16 days before the deadline. In the sector (NACE 75), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 July (4 of the last 5 accounts filed within 72 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Equity rose in 2025from €62,977 to €157,114 ▲ 149% View
  • Caution: Lower solvency than 85% of companies in veterinary activitiessector median 52.3% · 1,598 companies 13.0% View
  • Flemish supportawarded from 2022 to 2025 €964,508 View

Recent changes

  1. · Gazette deed Incorporation
All 10 events

Comparable companies

These companies have the same main activity as PATHOSENSE: veterinary services (NACE 75000). They are comparable in size and age: total assets between €1.1m and €1.6m, founded between 2019 and 2022.

CompanyTotal assetsGross margin
PATHOSENSE Lier€1.2m€0.7m
Jeraf Zoersel€1.4m€0.8m
VETLIFE Braine-l'Alleud€1.3m€0.6m
Via Nova Equine Services Bree€1.1m€0.6m
NIV-VET Nivelles€1.6m€0.6m
JULES WAUTERS EQUINE ORTHOPEDICS Merksplas€1.2m€0.6m
Dierenartsenpraktijk Desnoeck Puurs-Sint-Amands€1.2m€0.5m
Full comparison

Key facts about PATHOSENSE

What is the company number of PATHOSENSE?
The company number of PATHOSENSE is 0755.557.744. The VAT number is the same number with BE in front: BE 0755.557.744.
Where is PATHOSENSE based?
The registered office is at Pastoriestraat 10, 2500 Lier.Company details
What does PATHOSENSE do?
According to the KBO register, the main activity is veterinary services (NACE 75000).
What is the legal form of PATHOSENSE?
PATHOSENSE is a private limited company (BV).
When was PATHOSENSE founded?
PATHOSENSE was founded on 01-10-2020.
Is PATHOSENSE still active?
Yes, PATHOSENSE is an active enterprise in the KBO register.
How many employees does PATHOSENSE have?
PATHOSENSE had an average of 7.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PATHOSENSE?
The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €692,475 and 882 comparable companies of the same size. It probably lies between €970,000 and €2.0m. It is a rough estimate.
Is PATHOSENSE profitable?
In financial year 2025, PATHOSENSE made a profit of €94,137.
Where can I find the annual accounts of PATHOSENSE?
PATHOSENSE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PATHOSENSE due?
PATHOSENSE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.